BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23379410)

  • 1. Atypical antipsychotics for the treatment of disruptive behavior.
    Lohr WD; Honaker J
    Pediatr Ann; 2013 Feb; 42(2):72-7. PubMed ID: 23379410
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
    McDougle CJ; Stigler KA; Erickson CA; Posey DJ
    J Clin Psychiatry; 2008; 69 Suppl 4():15-20. PubMed ID: 18533764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents.
    Findling RL
    J Clin Psychiatry; 2008; 69 Suppl 4():9-14. PubMed ID: 18533763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching antipsychotic medications: not enough, too often, or just right?
    Weiden PJ
    Am J Psychiatry; 2011 Sep; 168(9):882-4. PubMed ID: 21890800
    [No Abstract]   [Full Text] [Related]  

  • 5. Second-generation antipsychotics cause weight gain in youths.
    Harv Ment Health Lett; 2010 Jan; 26(7):7. PubMed ID: 20217902
    [No Abstract]   [Full Text] [Related]  

  • 6. Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications.
    Wang PS; Schneeweiss S; Setoguchi S; Patrick A; Avorn J; Mogun H; Choudhry NK; Brookhart MA
    J Clin Psychopharmacol; 2007 Dec; 27(6):707-10. PubMed ID: 18004143
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer?
    Dubois D
    Curr Opin Pediatr; 2005 Apr; 17(2):227-33. PubMed ID: 15800418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.
    Citrome L; Volavka J
    Postgrad Med; 2004 Oct; 116(4):49-51, 55-9, 63. PubMed ID: 15510593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP).
    Stroup TS; McEvoy JP; Ring KD; Hamer RH; LaVange LM; Swartz MS; Rosenheck RA; Perkins DO; Nussbaum AM; Lieberman JA;
    Am J Psychiatry; 2011 Sep; 168(9):947-56. PubMed ID: 21768610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of atypical antipsychotics in the treatment of schizophrenia.
    Jessen LM
    Manag Care; 2002 Jul; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of atypical antipsychotics after traumatic brain injury.
    Elovic EP; Jasey NN; Eisenberg ME
    J Head Trauma Rehabil; 2008; 23(2):132-5. PubMed ID: 18362767
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005.
    Pathak P; West D; Martin BC; Helm ME; Henderson C
    Psychiatr Serv; 2010 Feb; 61(2):123-9. PubMed ID: 20123816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania.
    Keck PE
    J Clin Psychiatry; 2005; 66 Suppl 3():5-11. PubMed ID: 15762829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization.
    Jin H; Shih PA; Golshan S; Mudaliar S; Henry R; Glorioso DK; Arndt S; Kraemer HC; Jeste DV
    J Clin Psychiatry; 2013 Jan; 74(1):10-8. PubMed ID: 23218100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of antipsychotics in the elderly: a focus on atypicals.
    Finkel S
    J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S258-65. PubMed ID: 15541166
    [No Abstract]   [Full Text] [Related]  

  • 16. Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder.
    van Winkel R; De Hert M; Wampers M; Van Eyck D; Hanssens L; Scheen A; Peuskens J
    J Clin Psychiatry; 2008 Mar; 69(3):472-9. PubMed ID: 18348593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated creatine kinase elevation under treatment with quetiapine, clozapine, and aripiprazole in an adolescent.
    Bachmann CJ; Nicksch B; de Lange D; Theisen FM; Remschmidt H
    J Clin Psychopharmacol; 2007 Dec; 27(6):710-1. PubMed ID: 18004144
    [No Abstract]   [Full Text] [Related]  

  • 18. Two new atypical antipsychotics: advantages and disadvantages.
    Lemon MD
    S D J Med; 1998 Aug; 51(8):285-6. PubMed ID: 9724957
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic effects of the atypical antipsychotics.
    Wooten J
    South Med J; 2007 Aug; 100(8):771-2. PubMed ID: 17713300
    [No Abstract]   [Full Text] [Related]  

  • 20. Confounding by indication of a specific antipsychotic and the increase of body mass index among children and adolescents.
    Martínez-Ortega JM; Diaz-Atienza F; Gutiérrez-Rojas L; Jurado D; Gurpegui M
    Eur Child Adolesc Psychiatry; 2011 Dec; 20(11-12):597-8. PubMed ID: 21927910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.